Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P350
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bao, Xingfeng
Albu, Diana
Huang, Kuan-Chun
Wu, Jiayi
Twine, Natalie
Nomoto, Kenichi
Woodall-Jappe, Mary
Article History
First Online: 4 November 2015